My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 616

    1.

    5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside causes acute hepatic insulin resistance in vivo.

    Pencek RR, Shearer J, Camacho RC, James FD, Lacy DB, Fueger PT, Donahue EP, Snead W, Wasserman DH.

    Diabetes. 2005 Feb;54(2):355-60.PMID: 15677492 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Portal venous 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion overcomes hyperinsulinemic suppression of endogenous glucose output.

    Camacho RC, Pencek RR, Lacy DB, James FD, Donahue EP, Wasserman DH.

    Diabetes. 2005 Feb;54(2):373-82.PMID: 15677495 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin.

    Camacho RC, Lacy DB, James FD, Donahue EP, Wasserman DH.

    Am J Physiol Endocrinol Metab. 2005 Dec;289(6):E1039-43. Epub 2005 Jul 26.PMID: 16046457 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.

    Bergeron R, Previs SF, Cline GW, Perret P, Russell RR 3rd, Young LH, Shulman GI.

    Diabetes. 2001 May;50(5):1076-82.PMID: 11334411 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats.

    Iglesias MA, Ye JM, Frangioudakis G, Saha AK, Tomas E, Ruderman NB, Cooney GJ, Kraegen EW.

    Diabetes. 2002 Oct;51(10):2886-94. Erratum in: Diabetes 2003 Jan;52(1):223-4. PMID: 12351423 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion.

    Christopher M, Rantzau C, Chen ZP, Snow R, Kemp B, Alford FP.

    Am J Physiol Endocrinol Metab. 2006 Nov;291(5):E1131-40. Epub 2006 Jun 13.PMID: 16772328 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside reduces glucose uptake via the inhibition of Na+/H+ exchanger 1 in isolated rat ventricular cardiomyocytes.

    Ségalen C, Longnus SL, Baetz D, Counillon L, Van Obberghen E.

    Endocrinology. 2008 Apr;149(4):1490-8. Epub 2008 Jan 10.PMID: 18187546 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome.

    Buhl ES, Jessen N, Pold R, Ledet T, Flyvbjerg A, Pedersen SB, Pedersen O, Schmitz O, Lund S.

    Diabetes. 2002 Jul;51(7):2199-206.PMID: 12086950 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    A negative arterial-portal venous glucose gradient decreases skeletal muscle glucose uptake.

    Galassetti P, Shiota M, Zinker BA, Wasserman DH, Cherrington AD.

    Am J Physiol. 1998 Jul;275(1 Pt 1):E101-11.PMID: 9688880 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Suppression of endogenous glucose production by mild hyperinsulinemia during exercise is determined predominantly by portal venous insulin.

    Camacho RC, Pencek RR, Lacy DB, James FD, Wasserman DH.

    Diabetes. 2004 Feb;53(2):285-93.PMID: 14747277 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog.

    Sindelar DK, Balcom JH, Chu CA, Neal DW, Cherrington AD.

    Diabetes. 1996 Nov;45(11):1594-604.PMID: 8866566 [PubMed - indexed for MEDLINE]Related articles

    12.

    Portal vein caffeine infusion enhances net hepatic glucose uptake during a glucose load in conscious dogs.

    Pencek RR, Battram D, Shearer J, James FD, Lacy DB, Jabbour K, Williams PE, Graham TE, Wasserman DH.

    J Nutr. 2004 Nov;134(11):3042-6.PMID: 15514273 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Differential effects of insulin on splanchnic and peripheral glucose disposal after an intravenous glucose load in man.

    Saccà L, Cicala M, Trimarco B, Ungaro B, Vigorito C.

    J Clin Invest. 1982 Jul;70(1):117-26.PMID: 6123524 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    AMP-activated protein kinase activation by AICAR increases both muscle fatty acid and glucose uptake in white muscle of insulin-resistant rats in vivo.

    Iglesias MA, Furler SM, Cooney GJ, Kraegen EW, Ye JM.

    Diabetes. 2004 Jul;53(7):1649-54.PMID: 15220186 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog.

    Shiota M, Galassetti P, Monohan M, Neal DW, Cherrington AD.

    Diabetes. 1998 Jun;47(6):867-73.PMID: 9604861 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    AMPK activation with AICAR provokes an acute fall in plasma [K+].

    Zheng D, Perianayagam A, Lee DH, Brannan MD, Yang LE, Tellalian D, Chen P, Lemieux K, Marette A, Youn JH, McDonough AA.

    Am J Physiol Cell Physiol. 2008 Jan;294(1):C126-35. Epub 2007 Nov 14.PMID: 18003746 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Inhibition of insulin-stimulated glycogen synthesis by 5-aminoimidasole-4-carboxamide-1-beta-d-ribofuranoside-induced adenosine 5'-monophosphate-activated protein kinase activation: interactions with Akt, glycogen synthase kinase 3-3alpha/beta, and glycogen synthase in isolated rat soleus muscle.

    Fediuc S, Gaidhu MP, Ceddia RB.

    Endocrinology. 2006 Nov;147(11):5170-7. Epub 2006 Jul 27.PMID: 16873531 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Exercise-induced changes in insulin and glucagon are not required for enhanced hepatic glucose uptake after exercise but influence the fate of glucose within the liver.

    Pencek RR, James FD, Lacy DB, Jabbour K, Williams PE, Fueger PT, Wasserman DH.

    Diabetes. 2004 Dec;53(12):3041-7.PMID: 15561932 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Basal hepatic glucose production is regulated by the portal vein insulin concentration.

    Sindelar DK, Chu CA, Venson P, Donahue EP, Neal DW, Cherrington AD.

    Diabetes. 1998 Apr;47(4):523-9.PMID: 9568682 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Magnitude of negative arterial-portal glucose gradient alters net hepatic glucose balance in conscious dogs.

    Pagliassotti MJ, Myers SR, Moore MC, Neal DW, Cherrington AD.

    Diabetes. 1991 Dec;40(12):1659-68.PMID: 1684554 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity